In vitro amplification of nucleic acid molecules via circular replicons
First Claim
Patent Images
1. An in vitro composition for exponentially amplifying in vitro a target polynucleotide region of a nucleic acid molecule, wherein said composition comprises:
- (A) a single-stranded first polynucleotide, wherein said polynucleotide (i) contains a polynucleotide region that is complementary in sequence to said target polynucleotide region, and (ii) is a circular polynucleotide or is circularizable when hybridized to a polynucleotide comprising said target polynucleotide region;
(B) a second polynucleotide said second polynucleotide being a primer having a 3′
terminus hybridized to said single-stranded first polynucleotide and comprising said target polynucleotide region;
(C) a third polynucleotide, said third polynucleotide being a primer and comprising a polynucleotide region that is complementary in sequence to a region of said second polynucleotide, and whose 3′
terminus is hybridized thereto; and
(D) a polymerase, wherein said polymerase extends the 3′
termini of said second and third polynucleotides in a template-dependent manner to thereby provide said exponential amplification of said target polynucleotide region.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods and compositions suitable for accomplishing the in vitro amplification of nucleic acid molecules via enzymatic means are provided. The preferred means employ circular rather than linear replicons. Means for producing such circular replicons from linear reactants are also provided.
-
Citations
20 Claims
-
1. An in vitro composition for exponentially amplifying in vitro a target polynucleotide region of a nucleic acid molecule, wherein said composition comprises:
-
(A) a single-stranded first polynucleotide, wherein said polynucleotide (i) contains a polynucleotide region that is complementary in sequence to said target polynucleotide region, and (ii) is a circular polynucleotide or is circularizable when hybridized to a polynucleotide comprising said target polynucleotide region;
(B) a second polynucleotide said second polynucleotide being a primer having a 3′
terminus hybridized to said single-stranded first polynucleotide and comprising said target polynucleotide region;
(C) a third polynucleotide, said third polynucleotide being a primer and comprising a polynucleotide region that is complementary in sequence to a region of said second polynucleotide, and whose 3′
terminus is hybridized thereto; and
(D) a polymerase, wherein said polymerase extends the 3′
termini of said second and third polynucleotides in a template-dependent manner to thereby provide said exponential amplification of said target polynucleotide region.- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A kit for exponentially amplifying, in vitro, a target polynucleotide region of a nucleic acid molecule, wherein said kit comprises:
-
(A) a first container, said first container containing a single-stranded first polynucleotide, wherein said polynucleotide (i) contains a polynucleotide region that is complementary in sequence to said target polynucleotide region, and (ii) is a circular polynucleotide or is circularizable when hybridized to a polynucleotide comprising said target polynucleotide region; and
(B) a second container, said second container containing a second polynucleotide, said second polynucleotide being a primer having a 3′
terminus hybridized to said single-stranded first polynucleotide and comprising said target polynucleotide region; and
(C) a third container, said third container containing a third polynucleotide, said third polynucleotide being a primer and comprising a polynucleotide region that is complementary in sequence to a region of said second polynucleotide, and whose 3′
terminus is hybridized thereto;
wherein, in the presence of a polymerase, said 3′
termini of said second and third polynucleotides are extended in a template-dependent manner to hereby provide said exponential amplification of said target polynucleotide region.- View Dependent Claims (15, 16, 17, 18, 19, 20)
-
Specification